Commentary: SU9516 increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy

Benzer Materyaller

• SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy
  Yazar:: Sarathy, Apurva, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy
  Yazar:: Wuebbles, Ryan D., ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Sunitinib promotes myogenic regeneration and mitigates disease progression in the mdx mouse model of Duchenne muscular dystrophy
  Yazar:: Fontelonga, Tatiana M, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy
  Yazar:: Rooney, Jachinta E., ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Impaired fetal muscle development and JAK-STAT activation mark disease onset and progression in a mouse model for merosin-deficient congenital muscular dystrophy
  Yazar:: Nunes, Andreia M., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)